Valens Semiconductor (VLN) director Yaacobi Tal details share, option and RSU holdings

Rhea-AI Filing Summary

Valens Semiconductor Ltd. director Yaacobi Tal filed an initial ownership report showing direct holdings in ordinary shares and equity awards. He holds 78,798 ordinary shares and three stock option grants over 55,710, 35,689 and 56,804 underlying shares at exercise prices of $2.1280, $2.4100 and $1.6600, expiring between 2031 and 2033. The filing also notes 47,847 restricted share units granted on January 15, 2026 with quarterly vesting through January 15, 2027. Under a management agreement, all ordinary shares received from future option exercises and RSU vesting will be assigned to Value Base Ltd., with Yaacobi disclaiming beneficial ownership except for any pecuniary interest.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yaacobi Tal

(Last) (First) (Middle)

8 HANAGAR ST.

POB 7152

(Street)

HOD HASHARON 4501309

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/20/2026

3. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, no par value	78,798(1)	D(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	12/30/2024(3)	09/30/2031	Ordinary shares, no par value	55,710	$2.128	D(4)
Stock Option (Right to Buy)	04/15/2025(5)	01/15/2032	Ordinary shares, no par value	35,689	$2.41	D(6)
Stock Option (Right to Buy)	04/15/2026(7)	01/15/2033	Ordinary shares, no par value	56,804	$1.66	D(8)

Explanation of Responses:

1. Includes 47,847 restricted share units ("RSUs") granted on January 15, 2026, with 11,962 vesting on each of April 15, 2026, July 14, 2026, and October 12, 2026, and 11,961 vesting on January 15, 2027. Each RSU represents a contingent right to receive one ordinary share of the Company.

2. Pursuant to his management agreement with Value Base Ltd. ("Value Base"), Mr. Yaacobi will assign to Value Base all ordinary shares received following the exercise of his stock options or the vesting of his RSUs, which will be allocated to entities affiliated with Value Base. Mr. Yaacobi disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

3. Stock options were granted on September 30, 2024, with 4,643 vested on each of December 30, 2024, June 30, 2025, March 30, 2026, September 30, 2026, December 30, 2026 and June 30, 2027; 4,642 vesting on each of March 30, 2025, September 30, 2025, December 30, 2025, June 30, 2026, March 30, 2027, and September 30, 2027.

4. Pursuant to his management agreement with Value Base Ltd. ("Value Base"), Mr. Yaacobi will assign to Value Base all ordinary shares received following the exercise of his stock options or the vesting of his RSUs, which will be allocated to entities affiliated with Value Base. Mr. Yaacobi disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein

5. Stock options were granted on January 15, 2025, with 8,922 vested on each of April 15, 2025, October 12, 2025 and January 15, 2026, and 8,923 vested on July 14, 2025.

6. Pursuant to his management agreement with Value Base Ltd. ("Value Base"), Mr. Yaacobi will assign to Value Base all ordinary shares received following the exercise of his stock options or the vesting of his RSUs, which will be allocated to entities affiliated with Value Base. Mr. Yaacobi disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein

7. Stock options were granted on January 15, 2026, with 14,201 vesting on each of April 15, 2026, July 14, 2026, October 12, 2026, and January 15, 2027.

8. Pursuant to his management agreement with Value Base Ltd. ("Value Base"), Mr. Yaacobi will assign to Value Base all ordinary shares received following the exercise of his stock options or the vesting of his RSUs, which will be allocated to entities affiliated with Value Base. Mr. Yaacobi disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein

Remarks:

This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

	Tal Yaacobi by: Oppenheimer Israel, as Attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Yaacobi Tal’s Form 3 filing for Valens Semiconductor (VLN) show?

The Form 3 shows Yaacobi Tal’s initial ownership in Valens Semiconductor. It lists 78,798 ordinary shares, multiple stock option grants over more than 148,000 underlying shares, and 47,847 restricted share units with a detailed vesting schedule through January 2027.

How many ordinary shares does Yaacobi Tal hold in Valens Semiconductor (VLN)?

The filing reports that Yaacobi Tal directly holds 78,798 ordinary shares with no par value. This figure reflects his direct equity stake at the time of the Form 3 and is separate from additional exposure through stock options and restricted share units.

What stock options are reported for Yaacobi Tal in Valens Semiconductor (VLN)?

The Form 3 lists three option grants over 55,710, 35,689 and 56,804 underlying ordinary shares. Exercise prices are $2.1280, $2.4100 and $1.6600, with expiration dates in 2031, 2032 and 2033, giving long-dated potential equity exposure.

What restricted share units (RSUs) does Yaacobi Tal have in Valens Semiconductor (VLN)?

The filing states he has 47,847 RSUs granted on January 15, 2026. Vesting occurs in four tranches: 11,962 RSUs each on April 15, July 14 and October 12, 2026, and 11,961 RSUs on January 15, 2027, each convertible into one ordinary share.

How does Yaacobi Tal’s agreement with Value Base Ltd. affect his Valens (VLN) holdings?

Under a management agreement, Yaacobi Tal will assign to Value Base Ltd. all ordinary shares received from future option exercises and RSU vesting. These shares will be allocated to entities affiliated with Value Base, and he disclaims beneficial ownership except for any pecuniary interest.

Does Yaacobi Tal’s Form 3 indicate recent buying or selling of Valens (VLN) shares?

The Form 3 functions as an initial ownership snapshot and shows holdings rather than explicit purchases or sales. The transactions are categorized as holdings, with no buy or sell transaction codes, focusing on existing shares, options and RSUs as of the reporting date.